National Health (April 2024 Price Reductions) (Exercise of Ministerial discretion) Determination (No.1) 2024

Overview

The National Health (April 2024 Price Reductions) (Exercise of Ministerial Discretion) Determination (No. 1) 2024 was enacted to address specific pricing adjustments for certain pharmaceutical items under the National Health Act 1953. This legislation was introduced by Nikolai Tsyganov, the Assistant Secretary of the Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, as a delegate of the Minister for Health and Aged Care. The policy objective behind this determination is to regulate the prices of pharmaceutical items by reducing or exempting certain brands from the price reduction measures that would otherwise apply on April 1, 2024. The enacting body is the Parliament of Australia, which authorised the Minister to make such determinations under specific subsections of the Act. This determination specifies which pharmaceutical brands will not be subject to price reductions, which will have a reduced price that is lower than the standard reduction, and provides a detailed list of these items in the accompanying schedules. The goal is to ensure that certain medications, especially those critical for specific health conditions, remain affordable and accessible to the public while still achieving the broader objective of cost reductions within the pharmaceutical sector. The legislative framework ensures that the Minister’s discretion is exercised in a manner that aligns with the overarching goals of the National Health Act 1953.

Scope and Application

The National Health (April 2024 Price Reductions) (Exercise of Ministerial discretion) Determination (No.1) 2024 applies to the approved ex-manufacturer prices and claimed prices (where applicable) of pharmaceutical items listed in the schedules of the determination. These items include specific brands of pharmaceutical products such as combination items and single brands of pharmaceutical items, which are specified in Schedules 1, 2, and 3. The determination is made under the authority of the National Health Act 1953 and is effective from the day it is registered. The Act allows for the exercise of ministerial discretion to determine whether certain pharmaceutical items should be subject to price reductions or a lower percentage of reduction on 1 April 2024. Some pharmaceutical items are exempted from price reductions, while others are subject to a reduced percentage of price reduction compared to what would otherwise apply. This determination extends the application of the Act by specifying particular pharmaceutical items that are not subject to certain price reductions or are subject to a lower reduction.

Key Provisions

The National Health (April 2024 Price Reductions) (Exercise of Ministerial discretion) Determination (No.1) 2024, made under the National Health Act 1953, provides specific directions regarding the pricing of certain pharmaceutical items for April 2024. Section 5 of the Determination sets out which combination pharmaceutical items will not have their approved ex-manufacturer prices reduced, while Section 6 specifies which individual pharmaceutical items will also be exempt from price reductions. Additionally, Section 7 indicates which pharmaceutical items will have a lower percentage price reduction applied compared to the standard reduction. These provisions are effective from the date the instrument is registered. The obligations imposed by this Determination on the parties governed by it primarily involve adherence to the specified price reductions or exemptions for the listed pharmaceutical items. Manufacturers and suppliers of the listed pharmaceutical items must ensure that the prices of these items comply with the Determination's stipulations from the effective date. This includes not reducing the prices of the items listed in Sections 5 and 6 and applying the lower percentage reductions outlined in Section 7 to the items specified. Failure to comply with the price reduction or exemption provisions as outlined in this Determination may result in enforcement actions under the National Health Act 1953. While the Determination itself does not explicitly state penalties, the Act may impose penalties for non-compliance, which could include fines or other civil or criminal sanctions. The exact penalties would depend on the specific provisions of the National Health Act 1953 that apply to the non-compliant actions.